Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$862K Sell
12,185
-3,341
-22% -$250K 0.08% 215
2025
Q4
$1.23M Buy
15,526
+176
+1% +$13.9K 0.12% 153
2025
Q3
$1.26M Sell
15,350
-338
-2% -$26.6K 0.13% 152
2025
Q2
$1.26M Sell
15,688
-1,875
-11% -$145K 0.14% 152
2025
Q1
$1.41M Buy
17,563
+1,527
+10% +$127K 0.16% 121
2024
Q4
$1.31M Buy
16,036
+1,530
+11% +$127K 0.15% 142
2024
Q3
$1.2M Buy
14,506
+7,523
+108% +$562K 0.14% 159
2024
Q2
$490K Sell
6,983
-1,132
-14% -$80.8K 0.1% 222
2024
Q1
$601K Buy
8,115
+4,906
+153% +$342K 0.12% 187
2023
Q4
$212K Sell
3,209
-4,471
-58% -$280K 0.04% 248
2023
Q3
$483K Buy
+7,680
New +$478K 0.16% 131

Other funds holding MET

Norden Group's MET Position: Q1 2026 in Review

Norden Group reduced its MetLife (MET) stake by 22% in Q1 2026, selling an estimated $250K and leaving 12,185 shares worth $862K. The position accounts for 0.08% of the portfolio, ranked #215.

Norden Group first reported a position in MET in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.41M in Q1 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Norden Group held 12,185 shares of MetLife worth $862K as of Q1 2026.
  • Norden Group sold 3,341 MetLife shares in Q1 2026, an estimated $250K.
  • MetLife made up 0.08% of Norden Group's portfolio in Q1 2026, its #215 holding.
  • Norden Group first reported a position in MetLife in Q3 2023 and has held it in 11 quarters since.
  • Norden Group's MetLife position peaked at $1.41M in Q1 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Norden Group's 13F filing for Q1 2026, filed 15 Apr 2026.